Document is current
Any future updates will be listed below
-
Authors
Beasley, Georgia M https://orcid.org/0000-0001-6387-9030
Nair, Smita K
Farrow, Norma E
Landa, Karenia
Selim, Maria Angelica
Wiggs, Carol Ann
Jung, Sin-Ho
Bigner, Darell D
True Kelly, Andrea
Gromeier, Matthias
Salama, April KS
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct03712358 at ClinicalTrials.govDocuments that mention this clinical trial
Multimodality analysis confers a prognostic benefit of a T-cell infiltrated tumor microenvironment and peripheral immune status in patients with melanoma
https://doi.org/10.1136/jitc-2022-005052
302 A phase I trial of intratumoral PVSRIPO in patients with unresectable treatment refractory melanoma
https://doi.org/10.1136/jitc-2020-sitc2020.0302
Phase I trial of intratumoral PVSRIPO in patients with unresectable, treatment-refractory melanoma
https://doi.org/10.1136/jitc-2020-002203
Intratumor childhood vaccine-specific CD4<sup>+</sup> T-cell recall coordinates antitumor CD8<sup>+</sup> T cells and eosinophils
https://doi.org/10.1136/jitc-2022-006463
-
Funding
Funding for this research was provided by:
National Institution of Health (CA014236)
National Institution of Health (K08 CA237726-01A1)
National Institution of Health (T32-CA093245)
U.S. Department of Defense (W81XWH-16-1-0354)
Istari Oncology
- License Information
